Mprs Biological Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.80 M
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
- Revenue Growth -3.76%
- Profit Growth 209.82%
- Ebitda 76.34%
- Net Worth 163.90%
- Total Assets 46.47%
About Mprs Biological
Mprs Biological Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 March 2014 and has a history of Ten years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹2.00 M.
Manish Singh, Rajesh Gupta, and Sharad Singh serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33110DL2014PTC267306
-
Company No.
267306
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Mar 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Mprs Biological Private Limited offer?
Mprs Biological Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Biochemistry Analyzer, IVDs & Analyzers, Rapid Test Kit.
Who are the key members and board of directors at Mprs Biological?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Manish Singh | Director | 31-Mar-2014 | Current |
Rajesh Gupta | Director | 02-Jul-2020 | Current |
Sharad Singh | Director | 28-Sep-2016 | Current |
Financial Performance of Mprs Biological.
Mprs Biological Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.76% decrease. The company also saw a substantial improvement in profitability, with a 209.82% increase in profit. The company's net worth Soared by an impressive increase of 163.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Mprs Biological?
In 2023, Mprs Biological had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.20 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 May 2023 | Hdfc Bank Limited | ₹2.00 M | Open |
How Many Employees Work at Mprs Biological?
Unlock and access historical data on people associated with Mprs Biological, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mprs Biological, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mprs Biological's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.